External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients-Reference-Cited by-同舟云学术

External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients

Published:2023-12 Issue: Volume:35 Page:347-353
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Qin Yan^ORCID,Jiao Zheng^ORCID,Ye Yan-Rong,Shen Yun,Chen Zhe,Chen Yue-Ting,Li Xiao-Yu,Lv Qian-Zhou

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference54 articles.

1. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program;Meagher;Antimicrob Agents Chemother,2003

2. Safety and tolerability profile of second-line anti-tuberculosis medications;Ramachandran;Drug Saf,2015

3. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections;MacGowan;J Antimicrob Chemother,2003

4. Population pharmacokinetics and pharmacodynamics of linezolid-induced thrombocytopenia in hospitalized patients;Tsuji;Br J Clin Pharmacol,2017

5. Pharmacokinetics, pharmacodynamics, and tolerability of single-dose oral LCB01-0371, a novel oxazolidinone with broad-spectrum activity, in healthy volunteers;Cho;Antimicrob Agents Chemother,2018

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corrigendum to “External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients” [Journal of Global Antimicrobial Resistance 35 (2023) 347-353];Journal of Global Antimicrobial Resistance;2023-12